Cargando…

Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy

Introduction Oxaliplatin-based chemotherapy is the standard treatment in stage III colon cancer. Oxaliplatin may cause sinusoidal damage and sinusoidal obstruction syndrome (SOS) in the liver. Clinical reflections of SOS are splenomegaly and thrombocytopenia. This study aimed to investigate the freq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eren, Tulay, Pasaoglu, Lale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Radiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145381/ https://www.ncbi.nlm.nih.gov/pubmed/32280572 http://dx.doi.org/10.7759/cureus.7230

Ejemplares similares

Correction: Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
por: Eren, Tulay, et al.
Publicado: (2020)

A Case of Liver Fibrosis with Splenomegaly after Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer
por: Kang, Gu Hyum, et al.
Publicado: (2013)

Splenomegaly during oxaliplatin-based chemotherapy: impact on blood parameters and anti-neoplastic treatment
por: Ji, Ruoyu, et al.
Publicado: (2022)

Protective effect of Korean red ginseng on oxaliplatin-mediated splenomegaly in colon cancer
por: Kang, Jeonghyun, et al.
Publicado: (2018)

Predictors of Neoplasia in Colonic Wall Thickening Detected via Computerized Tomography
por: Karacin, Cengiz, et al.
Publicado: (2020)

Oxaliplatin-induced haematological toxicity and splenomegaly in mice
por: Lees, Justin G., et al.
Publicado: (2020)

ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
por: Baek, Moo-Jun
Publicado: (2015)

Oxaliplatin-induced Pulmonary Toxicity: A Rare but Serious Complication
por: Suthar, Krishna H, et al.
Publicado: (2020)

Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
por: Ishibashi, Keiichiro, et al.
Publicado: (2021)

Can Cross-Sectional Imaging Reliably Determine Pathological Staging of Right-Sided Colon Cancers and Select Patients for More Radical Surgery or Neo-Adjuvant Treatment?
por: Shekleton, Florence, et al.
Publicado: (2022)

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
por: Aitini, Enrico, et al.
Publicado: (2012)

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
por: Lesterhuis, W J, et al.
Publicado: (2010)

Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada
por: Attard, C.L., et al.
Publicado: (2010)

Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer
por: Eaton, Keith D, et al.
Publicado: (2021)

Expressions of 10 genes as candidate predictors of recurrence in stage III colon cancer patients receiving adjuvant oxaliplatin-based chemotherapy
por: Kumamoto, Kensuke, et al.
Publicado: (2019)

The Role of Ultrasound Features in Predicting the Breast Cancer Response to Neoadjuvant Chemotherapy
por: El-Diasty, Mohamed T, et al.
Publicado: (2023)

Synchronous Colon and Breast Cancers: A Case Report of Multiple Primary Tumors
por: Bin Saleem, Moneera Y, et al.
Publicado: (2022)

A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
por: Dejima, Akira, et al.
Publicado: (2023)

Asymptomatic Evolution and Regression of Temporal Lobe Necrosis After Adjuvant Radiation for Skin Cancer: A Case Report and Review of Literature
por: Pathak, Rima, et al.
Publicado: (2016)

Lipoma-Associated Intussusception of the Transverse Colon
por: Sui, Xiangliang, et al.
Publicado: (2023)

Chemotherapy Associated Bilateral Secondary Spontaneous Pneumothorax
por: Singh, Randeep, et al.
Publicado: (2022)

Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
por: Eggington, S, et al.
Publicado: (2006)

Adjuvant oxaliplatin-based chemotherapy effect after treatment of colorectal hepatic metastasis
por: Kang, Mee-Young, et al.
Publicado: (2021)

Sigmoid Colon Tuberculosis Revealed by a Perforation and Peritonitis
por: Ait Ali, Hassane, et al.
Publicado: (2020)

Analysis of reduced-dose administration of oxaliplatin as adjuvant FOLFOX chemotherapy for colorectal cancer
por: Park, Dawon, et al.
Publicado: (2018)

Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis
por: Huang, Wen-Kuan, et al.
Publicado: (2021)

ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
por: Zaanan, Aziz, et al.
Publicado: (2014)

Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection
por: Peng, Jianhong, et al.
Publicado: (2018)

Colo-Fallopian Fistula: A Rare Complication of Sigmoid Colon Diverticulitis
por: Jones, Daemar H, et al.
Publicado: (2023)

Stercoral Perforation of Sigmoid Colon in Systemic Lupus Erythematosus: A Rare Cause of Peritonitis
por: Latif, Ejaz, et al.
Publicado: (2020)

ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy
por: Li, P, et al.
Publicado: (2013)

The efficacy of oxaliplatin combination adjuvant chemotherapy for elderly patients with stage III colorectal cancer
por: Hayashi, Naomi, et al.
Publicado: (2020)

Oxaliplatin-Based Adjuvant Chemotherapy without Radiotherapy Can Improve the Survival of Locally-Advanced Rectal Cancer
por: Li, Jun, et al.
Publicado: (2014)

Open Pyelolithotomy in the Presence of a Retro-Renal Colon: A Safe Alternative in Resource-Limited Settings
por: Rhudd, Adrian R
Publicado: (2021)

The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study
por: Sue-Chue-Lam, Colin, et al.
Publicado: (2023)

Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer
por: Wang, Guoxiu, et al.
Publicado: (2018)

Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer
por: Fu, Xing-Li, et al.
Publicado: (2017)

The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
por: Collienne, Maike, et al.
Publicado: (2020)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Adjuvant Chemotherapy for Stage II Colon Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q8kr3km392jo2dtd7b3bd30mot